PINK:CSMYF

Cosmos Pharmaceutical Stock Earnings Reports

etoro logo Buy CSMYF
*Your capital is at risk
$37.06
+0 (+0%)
At Close: Aug 10, 2026

Cosmos Pharmaceutical Earnings Calls

May 28, 2026
$0.736 (-0.136%)
Release date Jul 13, 2026
EPS estimate $0.737
EPS actual $0.736
EPS Surprise -0.136%
Revenue estimate 1.797B
Revenue actual 1.815B
Revenue Surprise 1.03%
Feb 28, 2026
$0.655 (1.55%)
Release date Apr 13, 2026
EPS estimate $0.645
EPS actual $0.655
EPS Surprise 1.55%
Revenue estimate 1.72B
Revenue actual 1.75B
Revenue Surprise 1.74%
Nov 30, 2025
$0.523 (-2.79%)
Release date Jan 13, 2026
EPS estimate $0.538
EPS actual $0.523
EPS Surprise -2.79%
Revenue estimate 1.677B
Revenue actual 1.695B
Revenue Surprise 1.12%
Aug 31, 2025
$0.701 (-8.01%)
Release date Oct 14, 2025
EPS estimate $0.762
EPS actual $0.701
EPS Surprise -8.01%
Revenue estimate 1.868B
Revenue actual 1.852B
Revenue Surprise -0.83%

Last 4 Quarters for Cosmos Pharmaceutical

Below you can see how CSMYF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Aug 31, 2025 Missed
Release date Oct 14, 2025
Price on release $46.06
EPS estimate $0.762
EPS actual $0.701
EPS surprise -8.01%
Date Price
Oct 08, 2025 $46.06
Oct 09, 2025 $46.06
Oct 10, 2025 $61.39
Oct 13, 2025 $46.06
Oct 14, 2025 $46.06
Oct 15, 2025 $46.06
Oct 16, 2025 $46.06
Oct 17, 2025 $61.39
Oct 20, 2025 $46.06
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Nov 30, 2025 Missed
Release date Jan 13, 2026
Price on release $48.27
EPS estimate $0.538
EPS actual $0.523
EPS surprise -2.79%
Date Price
Jan 07, 2026 $48.27
Jan 08, 2026 $48.27
Jan 09, 2026 $48.27
Jan 12, 2026 $61.39
Jan 13, 2026 $48.27
Jan 14, 2026 $48.27
Jan 15, 2026 $48.27
Jan 16, 2026 $61.39
Jan 20, 2026 $48.27
4 days before 0%
4 days after -0.0021%
On release day -0.0021%
Change in period -0.0021%
Feb 28, 2026 Beat
Release date Apr 13, 2026
Price on release $48.27
EPS estimate $0.645
EPS actual $0.655
EPS surprise 1.55%
Date Price
Apr 07, 2026 $48.27
Apr 08, 2026 $48.27
Apr 09, 2026 $48.27
Apr 10, 2026 $48.27
Apr 13, 2026 $48.27
Apr 14, 2026 $48.27
Apr 15, 2026 $48.27
Apr 16, 2026 $48.27
Apr 17, 2026 $61.39
4 days before 0%
4 days after 27.18%
On release day 0%
Change in period 27.18%
May 28, 2026 Missed
Release date Jul 13, 2026
Price on release $37.06
EPS estimate $0.737
EPS actual $0.736
EPS surprise -0.136%
Date Price
Jul 07, 2026 $37.06
Jul 08, 2026 $37.06
Jul 09, 2026 $37.06
Jul 10, 2026 $37.06
Jul 13, 2026 $37.06
Jul 14, 2026 $37.06
Jul 15, 2026 $37.06
Jul 16, 2026 $37.06
Jul 17, 2026 $37.06
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%

Cosmos Pharmaceutical Earnings History

Earnings Calendar

FAQ

When is the earnings report for CSMYF?
Cosmos Pharmaceutical Corporation (CSMYF) has scheduled its earnings report for Oct 14, 2026 after the markets close.

What is the CSMYF price-to-earnings (P/E) ratio?
CSMYF P/E ratio as of Aug 10, 2026 (TTM) is 16.03.

What is the CSMYF EPS forecast?
The forecasted EPS (Earnings Per Share) for Cosmos Pharmaceutical Corporation (CSMYF) for the first fiscal quarter 2026 is $.

What are Cosmos Pharmaceutical Corporation's retained earnings?
On its balance sheet, Cosmos Pharmaceutical Corporation reported retained earnings of $1.82 billion for the latest quarter ending May 28, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE